Compound 127
Identifiers
- Canonical SMILES:
Nc1nnc(o1)-c1nc(C2CCCCC2)n(c1-c1ccc(F)c(Cl)c1)-c1c(CC(=O)Nc2cccc(F)c2)ccc(Cl)c1F
- InChi:
InChI=1S/C31H25Cl2F3N6O2/c32-21-11-9-18(14-24(43)38-20-8-4-7-19(34)15-20)27(25(21)36)42-28(17-10-12-23(35)22(33)13-17)26(30-40-41-31(37)44-30)39-29(42)16-5-2-1-3-6-16/h4,7-13,15-16H,1-3,5-6,14H2,(H2,37,41)(H,38,43)
- InChiKey:
RWYWCCRFKVBJBT-UHFFFAOYSA-N
External links
67032065 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 8.05 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 640.14 g/mol | |||
HBA | 8 | |||
HBD | 3 | |||
HBA + HBD | 11 | |||
AlogP | 6.78 | |||
TPSA | 111.86 | |||
RB | 6 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011023677 | 510 | MDM2 Q00987 |
|
Biochemical assay | Time-Resolved FRET | pIC50 (half maximal inhibitory concentration, -log10) | 8.05 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4158 | Azeliragon | DB12689 | |
0.4066 | LY-2584702 | DB12690 | |
0.4064 | Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB02388 | |
0.4062 | Velpatasvir | DB11613 | |
0.4043 | Selonsertib | DB14916 | |
0.4000 | Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB03084 | |
0.3975 | Atorvastatin | DB01076 | |
0.3896 | Otenabant | DB11745 | |
0.3880 | 1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine | DB02008 | |
0.3857 | AMG-510 | DB15569 | |
0.3846 | 4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine | DB01761 | |
0.3839 | BMS-986142 | DB15291 | |
0.3806 | N-6022 | DB12206 | |
0.3787 | Olmesartan | DB00275 | |
0.3758 | Ralimetinib | DB11787 |